NEU neuren pharmaceuticals limited

Ann: 2022 Annual Report to shareholders, page-2

  1. 1,484 Posts.
    lightbulb Created with Sketch. 376
    Such good reading, professional report and reads extremely upbeat.

    My biggest takeaway is Neuren's confidence in the ongoing trials moving to Phase 3 - IMO if they are preparing al;ready for the next phase it demonstrates high confidence (which is understandable given the mouse trial results).

    As good as the past 3 months has been, im excited for the next 6 months !
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$16.48
Change
-0.290(1.73%)
Mkt cap ! $2.076B
Open High Low Value Volume
$16.58 $16.74 $16.40 $9.107M 549.9K

Buyers (Bids)

No. Vol. Price($)
1 864 $16.43
 

Sellers (Offers)

Price($) Vol. No.
$16.50 1668 1
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.